BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27383662)

  • 1. Temporal patterns of
    Schwartz JS; Brooks SG; Stubbs V; Ghosh A; Tajudeen BA; Khalili S; Palmer JN; Lee JY; Nabavizadeh SA; Learned KO; Adappa ND
    Int Forum Allergy Rhinol; 2016 Dec; 6(12):1301-1307. PubMed ID: 27383662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of whole-body
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):847-855. PubMed ID: 30604061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate timing of surveillance intervals with whole-body
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    Eur J Radiol; 2019 Sep; 118():75-80. PubMed ID: 31439262
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Workman AD; Glicksman JT; Parasher AK; Carey RM; Brooks SG; Kennedy DW; Nabavizadeh SA; Learned KO; Palmer JN; Adappa ND
    Otolaryngol Head Neck Surg; 2017 Dec; 157(6):1068-1074. PubMed ID: 28809123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    AJR Am J Roentgenol; 2018 Dec; 211(6):1354-1360. PubMed ID: 30300005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of first positron emission tomography-computed tomography scan as a prognostic tool following treatment of sinonasal and skull base malignancies.
    Abu-Ghanem S; Yafit D; Ghanayem M; Abergel A; Yehuda M; Fliss DM
    Head Neck; 2019 Mar; 41(3):701-706. PubMed ID: 30521131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility of 18F-fluorodeoxyglucose-positron emission tomography uptake as a prognostic factor for paranasal sinus malignancy.
    Seol JH; Kim J; Lee JD; Lee JG; Yoon JH; Kim CH
    Am J Rhinol Allergy; 2013; 27(2):118-22. PubMed ID: 23562200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of
    Elkhatib AH; Soldatova L; Carrau RL; Hachem RA; Ditzel L; Campbell R; Prevedello DM; Prevedello L; Filho LF; Campbell RG
    Laryngoscope; 2017 Feb; 127(2):321-324. PubMed ID: 27481043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of survival with combining quantitative
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    Head Neck; 2019 Sep; 41(9):3080-3089. PubMed ID: 31041831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18-FDG-PET in the initial staging of sinonasal malignancy.
    Ramakrishnan VR; Lee JY; O'Malley BW; Palmer JN; Chiu AG
    Laryngoscope; 2013 Dec; 123(12):2962-6. PubMed ID: 23877974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET evaluation of sinonasal papilloma.
    Cohen EG; Baredes S; Zuckier LS; Mirani NM; Liu Y; Ghesani NV
    AJR Am J Roentgenol; 2009 Jul; 193(1):214-7. PubMed ID: 19542416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission computed tomography and magnetic resonance imaging features of sinonasal small round blue cell tumors.
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    Neuroradiol J; 2020 Feb; 33(1):48-56. PubMed ID: 31460836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Implications of Incidental Sinonasal Positive FDG Uptake on PET-CT.
    Tzelnick S; Bernstine H; Domachevsky L; Soudry E
    Otolaryngol Head Neck Surg; 2019 Apr; 160(4):729-733. PubMed ID: 30598053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study.
    Shmidt E; Nehra V; Lowe V; Oxentenko AS
    BMC Gastroenterol; 2016 Oct; 16(1):125. PubMed ID: 27716085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttreatment surveillance for sinonasal malignancy.
    Workman AD; Palmer JN; Adappa ND
    Curr Opin Otolaryngol Head Neck Surg; 2017 Feb; 25(1):86-92. PubMed ID: 27846019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopy versus imaging: Analysis of surveillance methods in sinonasal malignancy.
    Khalili S; Worrall DM; Brooks S; Morris SM; Farquhar D; Newman JG; Learned KO; Ahn PH; Craig J; Kennedy DW; O'Malley BW; Palmer JN; Adappa ND
    Head Neck; 2016 Aug; 38(8):1229-33. PubMed ID: 27142811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma.
    Leung AS; Rath TJ; Hughes MA; Kim S; Branstetter BF
    Head Neck; 2016 Apr; 38 Suppl 1():E853-8. PubMed ID: 25917499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between
    Felix-Ravelo M; Bey A; Arous F; Paris-Grandpierre S; Jankowski R; Nguyen DT
    Acta Otolaryngol; 2017 Feb; 137(2):191-195. PubMed ID: 27576899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.